Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04699591

Compassionate Use of Domperidone for Refractory Gastroparesis

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Jose Cocjin · Academic / Other
Sex
All
Age
12 Years – 21 Years
Healthy volunteers
Not accepted

Summary

The purpose of this program is to allow the use of domperidone in children from 12 to 21 years of age with symptoms related to motility disorders and Gastroesophageal reflux disease (GERD) who have failed all the standard treatments for their condition.

Detailed description

The following will need to be completed before the investigational treatment can begin: * Your medical history will be reviewed to make sure domperidone is a safe option for treatment * You will have a physical examination, including heart and breathing rates, blood pressure, height, weight, and an ECG. An ECG measures the electrical activity of the heart over a period of time. This is a non-invasive procedure and involves attaching sticky pads to your chest and recording your body's electrical activity on a machine. The study doctor/nurse will explain this in more detail to you. * You will have up to 3 teaspoons of blood drawn through a needle in the arm to make sure it is safe for you to receive domperidone. * You will have a pregnancy test if you are female. If your tests results are acceptable, the following will happen to you: * You will take domperidone 4 times per day. The dose will be calculated by your doctor according to your weight. * Every two months for the first year, you will have a physical examination, including heart and breathing rates, blood pressure, height, weight, up to 3 teaspoons of blood drawn through a needle in your arm to measure blood levels, and an ECG. * You will also have an ECG anytime there is an increase in the amount of domperidone you are taking. * After the first year, if you are benefitting from taking domperidone you will have a physical examination, blood draw and ECG every six months until you stop taking domperidone.

Conditions

Interventions

TypeNameDescription
DRUGDomperidoneDomperidone taken 4 times a day, dose based on body weight

Timeline

Start date
2013-04-01
Primary completion
2035-12-01
Completion
2035-12-01
First posted
2021-01-07
Last updated
2026-03-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04699591. Inclusion in this directory is not an endorsement.